Table 3.
Selected nontransplant studies with immunotoxins as monotherapy in AML
BM indicates bone marrow; DLT, dose-limiting toxicity; ND, newly diagnosed; PB, peripheral blood; R/R, relapsed/refractory.
Selected nontransplant studies with immunotoxins as monotherapy in AML
BM indicates bone marrow; DLT, dose-limiting toxicity; ND, newly diagnosed; PB, peripheral blood; R/R, relapsed/refractory.
